324 related articles for article (PubMed ID: 36418458)
1. The systemic renin-angiotensin system in COVID-19.
Reindl-Schwaighofer R; Hödlmoser S; Domenig O; Krenn K; Eskandary F; Krenn S; Schörgenhofer C; Rumpf B; Karolyi M; Traugott MT; Abrahamowicz A; Tinhof V; Mayfurth H; Rathkolb V; Mußnig S; Schmölz L; Ullrich R; Heinzel A; König F; Binder C; Bonderman D; Strassl R; Puchhammer-Stöckl E; Gorkiewicz G; Aberle JH; Jilma B; Wenisch C; Poglitsch M; Oberbauer R; Zoufaly A; Hecking M
Sci Rep; 2022 Nov; 12(1):20117. PubMed ID: 36418458
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P
Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316
[TBL] [Abstract][Full Text] [Related]
3. [Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the
Zuraeva ZT; Vikulova OK; Malysheva NM; Nikankina LV; Zaytceva NV; Sukhareva OY; Shamhalova MS; Shestakova MV; Mokrysheva NG
Probl Endokrinol (Mosk); 2023 Aug; 69(4):21-31. PubMed ID: 37694864
[TBL] [Abstract][Full Text] [Related]
4. A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure.
Files DC; Gibbs KW; Schaich CL; Collins SP; Gwathmey TM; Casey JD; Self WH; Chappell MC
Am J Physiol Lung Cell Mol Physiol; 2021 Jul; 321(1):L213-L218. PubMed ID: 34009036
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptors: Impact for COVID-19 severity.
Aksoy H; Karadag AS; Wollina U
Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
10. Influence of renin-angiotensin-aldosterone system inhibitors on plasma levels of angiotensin-converting enzyme 2.
Zimmermann T; Walter JE; Lopez-Ayala P; Strebel I; Amrein M; Koechlin M; Honegger U; Mueller C;
ESC Heart Fail; 2021 Apr; 8(2):1717-1721. PubMed ID: 34596976
[TBL] [Abstract][Full Text] [Related]
11. The fight against COVID-19: Striking a balance in the renin-angiotensin system.
Dean AQ; Bozza WP; Twomey JD; Luo S; Nalli A; Zhang B
Drug Discov Today; 2021 Oct; 26(10):2214-2220. PubMed ID: 33865979
[TBL] [Abstract][Full Text] [Related]
12. Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells.
Tonon F; Candido R; Toffoli B; Tommasi E; Cortello T; Fabris B; Bernardi S
Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1275-1282. PubMed ID: 35260304
[TBL] [Abstract][Full Text] [Related]
13. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells.
Caputo I; Caroccia B; Frasson I; Poggio E; Zamberlan S; Morpurgo M; Seccia TM; Calì T; Brini M; Richter SN; Rossi GP
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563515
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin I and II Stimulate Cell Invasion of SARS-CoV-2: Potential Mechanism via Inhibition of ACE2 Arm of RAS.
Zorad S; Skrabanova M; Zilkova M; Cente M; Turic Csokova N; Kovacech B; Cizkova D; Filipcik P
Physiol Res; 2024 Mar; 73(1):27-35. PubMed ID: 38466002
[TBL] [Abstract][Full Text] [Related]
16. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
[TBL] [Abstract][Full Text] [Related]
17. Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.
Hooper NM; Lambert DW; Turner AJ
Clin Sci (Lond); 2020 Sep; 134(18):2489-2501. PubMed ID: 32990314
[TBL] [Abstract][Full Text] [Related]
18. Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.
Cook JR; Ausiello J
Rev Endocr Metab Disord; 2022 Apr; 23(2):151-170. PubMed ID: 34195965
[TBL] [Abstract][Full Text] [Related]
19. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
Malek Mahdavi A
Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
Sackin H
Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
